Literature DB >> 30114349

Comparison between laparoscopy and laboratory tests for the diagnosis of tuberculous zzm321990peritonitis

Bo Huang, Ying Ren, Bin Han, Da Ping Yang, Xun Zhao.   

Abstract

Background/aim: Our study aimed to investigate a reliable diagnostic approach for tuberculous peritonitis (TBP) by comparing the commonly used diagnostic tools. Materials and methods: Fifty-one patients had received a series of diagnoses, including laparoscopy, erythrocyte sedimentation rate (ESR), cancer antigen 125 (CA125), tuberculin skin test, tuberculosis antibody in serum (TB-Ab), the T-SPOT.TB test, or adenosine deaminase (ADA) in ascitic fluid. The positive rate of each method was calculated and the differences of positive rates between laparoscopy and laboratory tests that had higher positive rates were analyzed by McNemar chi-square test.
Results: The most common symptoms and signs of 51 patients were fever (86.3%), abdominal mass (78.4%), abdominal distension (62.7%), abdominal pain (74.5%), and weight loss (66.7%). Furthermore, the positive rates of CA125, laparoscopy, T-SPOT.TB test, and ESR were relatively higher than those of the other three methods (tuberculin skin test, TB-Ab, and ascitic ADA). Additionally, there was no significant difference (P > 0.05) in the positive rates between the diagnoses of laparoscopy and those three laboratory tests.
Conclusion: CA125, laparoscopy, T-SPOT.TB test, and ESR had a stronger diagnostic power for TBP, and they are reliable alternatives for the diagnosis of TBP.

Entities:  

Keywords:  Tuberculous peritonitis; laparoscopy; cancer antigen 125; erythrocyte sedimentation rate; T-SPOT.TB

Mesh:

Substances:

Year:  2018        PMID: 30114349     DOI: 10.3906/sag-1512-147

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis.

Authors:  Xidong He; Yuanxue Gao; Qi Liu; Zhifang Zhao; Wanhang Deng; Hong Yang
Journal:  Gastroenterol Res Pract       Date:  2020-03-20       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.